JP2022506113A - 睡眠時無呼吸を治療するための方法及び組成物 - Google Patents

睡眠時無呼吸を治療するための方法及び組成物 Download PDF

Info

Publication number
JP2022506113A
JP2022506113A JP2021523282A JP2021523282A JP2022506113A JP 2022506113 A JP2022506113 A JP 2022506113A JP 2021523282 A JP2021523282 A JP 2021523282A JP 2021523282 A JP2021523282 A JP 2021523282A JP 2022506113 A JP2022506113 A JP 2022506113A
Authority
JP
Japan
Prior art keywords
oxybutynin
hydroxyatomoxetine
composition
subject
muscarinic receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021523282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022506113A5 (cg-RX-API-DMAC7.html
Inventor
ミラー,ローレンス,ジー.
ファーカス,ロナルド
Original Assignee
アプニメッド,インコーポレイテッド(デラウェア)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アプニメッド,インコーポレイテッド(デラウェア) filed Critical アプニメッド,インコーポレイテッド(デラウェア)
Publication of JP2022506113A publication Critical patent/JP2022506113A/ja
Publication of JP2022506113A5 publication Critical patent/JP2022506113A5/ja
Priority to JP2024062027A priority Critical patent/JP2024088740A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2021523282A 2018-10-31 2019-07-23 睡眠時無呼吸を治療するための方法及び組成物 Pending JP2022506113A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024062027A JP2024088740A (ja) 2018-10-31 2024-04-08 睡眠時無呼吸を治療するための方法及び組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862753420P 2018-10-31 2018-10-31
US62/753,420 2018-10-31
PCT/US2019/043065 WO2020091862A1 (en) 2018-10-31 2019-07-23 Methods and compositions for treating sleep apnea

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024062027A Division JP2024088740A (ja) 2018-10-31 2024-04-08 睡眠時無呼吸を治療するための方法及び組成物

Publications (2)

Publication Number Publication Date
JP2022506113A true JP2022506113A (ja) 2022-01-17
JP2022506113A5 JP2022506113A5 (cg-RX-API-DMAC7.html) 2022-07-27

Family

ID=67539629

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021523282A Pending JP2022506113A (ja) 2018-10-31 2019-07-23 睡眠時無呼吸を治療するための方法及び組成物
JP2024062027A Pending JP2024088740A (ja) 2018-10-31 2024-04-08 睡眠時無呼吸を治療するための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024062027A Pending JP2024088740A (ja) 2018-10-31 2024-04-08 睡眠時無呼吸を治療するための方法及び組成物

Country Status (9)

Country Link
US (4) US20210401790A1 (cg-RX-API-DMAC7.html)
EP (1) EP3873454A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022506113A (cg-RX-API-DMAC7.html)
KR (1) KR20210084481A (cg-RX-API-DMAC7.html)
CN (1) CN112930179A (cg-RX-API-DMAC7.html)
AU (1) AU2019370091A1 (cg-RX-API-DMAC7.html)
CA (1) CA3117766A1 (cg-RX-API-DMAC7.html)
MX (2) MX2021004883A (cg-RX-API-DMAC7.html)
WO (1) WO2020091862A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024523876A (ja) * 2021-06-17 2024-07-02 アプニメッド,インコーポレイテッド(デラウェア) 睡眠時無呼吸を治療するためのノルエピネフリン再取り込み阻害剤
MX2024007768A (es) * 2021-12-22 2024-07-01 Bayer Ag Combinacion de un antagonista de adrenoreceptor a2 subtipo c (alfa-2c) con un inhibidor de recaptacion de norepinefrina para el tratamiento de apnea del sue?o.
IL313648A (en) * 2021-12-22 2024-08-01 Bayer Ag Combination of a TASK1/3 channel blocker with a norepinephrine reuptake inhibitor for the treatment of sleep apnea
CN119789855A (zh) * 2022-09-02 2025-04-08 爱普宁公司(特拉华) 治疗睡眠呼吸暂停的方法和组合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523382A (ja) * 2000-02-24 2003-08-05 ファルマシア・アンド・アップジョン・カンパニー 新規な薬物の組合せ
JP2004525912A (ja) * 2001-03-06 2004-08-26 イーライ・リリー・アンド・カンパニー モノアミン取込の阻害剤
JP2012176958A (ja) * 2012-04-20 2012-09-13 Watson Pharmaceuticals Inc (r)−オキシブチニンおよび(r)−デスエチルオキシブチニンによる平滑筋機能亢進の処置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
PT1691811E (pt) * 2003-12-11 2014-10-30 Sunovion Pharmaceuticals Inc Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
US20080145318A1 (en) * 2006-12-13 2008-06-19 Midha Kamal K Atomoxetine formulations and associated methods
EP4011370A1 (en) * 2014-07-22 2022-06-15 Magnolia Cns, Llc Pharmaceutical compositions and method for the treatment of symptoms of panic and anxiety using beta adrenergic receptor antagonist and muscarinic receptor antagonist combinations
CN119185558A (zh) * 2017-04-28 2024-12-27 布里格姆妇女医院 用于治疗睡眠呼吸暂停的方法和组合物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523382A (ja) * 2000-02-24 2003-08-05 ファルマシア・アンド・アップジョン・カンパニー 新規な薬物の組合せ
JP2004525912A (ja) * 2001-03-06 2004-08-26 イーライ・リリー・アンド・カンパニー モノアミン取込の阻害剤
JP2012176958A (ja) * 2012-04-20 2012-09-13 Watson Pharmaceuticals Inc (r)−オキシブチニンおよび(r)−デスエチルオキシブチニンによる平滑筋機能亢進の処置

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Atomoxetine and Oxybutynin in Obstructive Sleep Apnea (ATOSA) / Study NCT02908529 on Date: January 1", CLINICALTRIALS.GOV ARCHIVE [ONLINE], JPN6022046544, 17 January 2018 (2018-01-17), ISSN: 0005215343 *
J CLIN PHARMACOL, vol. 42, JPN6023028340, 2002, pages 1219 - 1227, ISSN: 0005215344 *
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 256, no. 2, JPN6022046545, 1991, pages 562 - 567, ISSN: 0005215345 *

Also Published As

Publication number Publication date
MX2021004883A (es) 2021-08-05
WO2020091862A1 (en) 2020-05-07
US20210401790A1 (en) 2021-12-30
US20260165996A1 (en) 2026-06-18
MX2024013184A (es) 2024-12-06
KR20210084481A (ko) 2021-07-07
CA3117766A1 (en) 2020-05-07
AU2019370091A1 (en) 2021-05-27
US20250325510A1 (en) 2025-10-23
EP3873454A1 (en) 2021-09-08
JP2024088740A (ja) 2024-07-02
CN112930179A (zh) 2021-06-08
US20250114321A1 (en) 2025-04-10

Similar Documents

Publication Publication Date Title
US20250186371A1 (en) Methods and compositions for treating sleep apnea
JP7373997B2 (ja) 睡眠時無呼吸を治療する方法及び組成物
US20250114321A1 (en) Methods and compositions for treating sleep apnea
HK40117857A (en) Methods and compositions for treating sleep apnea
HK40031779A (en) Methods and compositions for treating sleep apnea or simple snoring
HK40031779B (en) Methods and compositions for treating sleep apnea or simple snoring
EA047115B1 (ru) Способы и композиции для лечения апноэ сна
EA045789B1 (ru) Способы и композиции для лечения апноэ во сне

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220715

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220715

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230706

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231005

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231010

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20231211